Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of developments.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into this market by partnering with developers like DEVCO or SJP Properties to co-GP on significant life sciences projects.

Co-GP / Platform:A family office could deploy into the life sciences market by backing a sponsor or operator at the GP level, focusing on projects in high-demand markets like Boston-Cambridge or San Francisco.

Co-GP / Platform:A family office could deploy into the Raleigh-Durham life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Denver-Boulder life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of innovative projects.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Bay Area life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity arrangements to share in the promote.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to align interests and share in the potential upside.

Co-GP / Platform:A family office could deploy into the San Francisco life science market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of new developments.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston life science market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the U.S. life sciences market by backing a sponsor or operator at the GP level, capitalizing on the growing demand for life science facilities adjacent to healthcare ecosystems.

Co-GP / Platform:A family office could deploy into Houston's life sciences market by backing a local operator or sponsor at the GP level, sharing in the promote and benefiting from the area's growth.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from their expertise.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Boston-Cambridge life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of new developments.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator involved in the development of large-scale lab facilities, sharing in the promote and enterprise value.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, particularly in funding large-scale life sciences developments.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level, particularly in the context of the new biotech developments and revitalization projects.

Co-GP / Platform:A family office could deploy into the Denver-Boulder life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a repeatable investment pipeline.